电子处方市场 - 全球产业规模、份额、趋势、机会和预测，按产品（解决方案）、服务、专业、交付模式、物质、地区和竞争细分，2019-2029F

2023 年全球电子处方市场估值为 25.2 亿美元，预计在预测期内将稳定成长，到 2029 年复合年增长率为 8.30%。患者护理。近年来获得巨大关注的一项创新是电子处方或电子处方。随着医疗保健提供者、药房和患者越来越认识到其好处，全球电子处方市场一直在大幅成长。电子处方通常称为电子处方，是一种数位解决方案，允许医疗保健提供者以电子方式产生处方单并将其传输到药房。它取代了传统的手写或印刷的纸质处方，为药物管理提供了更有效率、更准确的方法。电子处方涵盖各个组成部分，包括处方创建、即时用药历史记录访问、用药警报以及与电子健康记录 (EHR) 的连接。

市场概况
预测期	2025-2029
2023 年市场规模	25.2亿美元
2029 年市场规模	40.8亿美元
2024-2029 年复合年增长率	8.30%
成长最快的细分市场	解决方案
最大的市场	北美洲

电子处方减少了用药错误的可能性，例如字迹模糊和剂量不正确，从而提高了患者的安全性。它消除了手动输入的需要并减轻了医疗保健专业人员的管理负担，从而简化了处方流程。电子处方系统通常具有使患者能够接收用药提醒并存取相关资讯的功能，从而有助于提高依从性。电子处方解决方案越来越多地与电子健康记录集成，在护理点提供全面的患者资讯。许多国家的政府和监管机构鼓励采用电子处方，以提高医疗保健品质并降低成本。

主要市场驱动因素

增加政府措施和法规

提高效率和便利性

主要市场挑战

实施障碍

资料隐私和安全

用药错误和决策支持

主要市场趋势

技术进步

细分市场洞察

产品洞察

专业见解

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：全球电子处方市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品（解决方案（整合解决方案、独立解决方案）、服务（支援、实施、培训、网路）
  • 按专业（肿瘤学、运动医学、神经病学、心臟科、其他）
  • 依交付模式（基于 Web/云端、内部部署）
  • 依物质分类（管理物质、非管理物质）
  • 按地区
  • 按公司划分 (2023)
• 市场地图
  • 按产品分类
  • 按专业
  • 按交付方式
  • 按物质分类
  • 按地区

第 5 章：亚太地区电子处方市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按专业
  • 按交付方式
  • 按物质分类
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第 6 章：欧洲电子处方市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按专业
  • 按交付方式
  • 按物质分类
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第 7 章：北美电子处方市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按专业
  • 按交付方式
  • 按物质分类
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第 8 章：南美洲电子处方市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按专业
  • 按交付方式
  • 按物质分类
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 9 章：中东和非洲电子处方市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按产品分类
  • 按专业
  • 按交付方式
  • 按物质分类
  • 按国家/地区
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 10 章：市场动态

• 司机
• 挑战

第 11 章：市场趋势与发展

• 最近的发展
• 产品发布
• 併购

第 12 章：全球电子处方市场：SWOT 分析

第 13 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第14章：竞争格局

• Oracle Corp.
• Veradigm LLC
• Epic Systems Corporation
• Athenahealth, Inc.
• NextGen Healthcare, Inc.
• McKesson Corporation
• Surescripts, LLC
• Change Healthcare LLC
• Practice Fusion, Inc.
• Networking Technology, Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

Global E-Prescribing Market was valued at USD 2.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 8.30% through 2029. In the ever-evolving landscape of healthcare, technological advancements continue to shape the way medical professionals deliver patient care. One such innovation that has gained significant traction in recent years is electronic prescribing, or e-prescribing. The Global E-Prescribing Market has been experiencing substantial growth as healthcare providers, pharmacies, and patients increasingly recognize its benefits. Electronic prescribing, commonly referred to as e-prescribing, is a digital solution that allows healthcare providers to generate and transmit prescription orders electronically to pharmacies. It replaces traditional handwritten or printed paper prescriptions, offering a more efficient and accurate method for medication management. E-prescribing encompasses various components, including the creation of prescriptions, real-time medication history access, medication alerts, and connectivity to electronic health records (EHRs).

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 2.52 Billion
Market Size 2029	USD 4.08 Billion
CAGR 2024-2029	8.30%
Fastest Growing Segment	Solutions
Largest Market	North America

E-prescribing reduces the potential for medication errors, such as illegible handwriting and incorrect dosages, resulting in improved patient safety. It streamlines the prescription process by eliminating the need for manual entry and reducing administrative burdens on healthcare professionals. E-prescribing systems often come with features that enable patients to receive medication reminders and access relevant information, contributing to improved adherence. E-prescribing solutions are increasingly integrated with electronic health records, providing comprehensive patient information at the point of care. Governments and regulatory bodies in many countries have encouraged the adoption of e-prescribing to enhance healthcare quality and reduce costs.

Key Market Drivers

Increasing Government Initiatives and Regulations

The global healthcare landscape is evolving at a rapid pace, with technological advancements playing a pivotal role in transforming the way medical services are delivered. One such technological revolution in healthcare is the adoption of electronic prescribing, commonly known as e-prescribing. E-prescribing is a digital solution that streamlines the prescription process, ensuring accuracy, efficiency, and patient safety. In recent years, the global e-prescribing market has witnessed substantial growth, largely fueled by increasing government initiatives and regulations aimed at enhancing healthcare quality and reducing medication errors.

The growth of the global e-prescribing market can be primarily attributed to the increasing support and guidance from governments and regulatory bodies. These initiatives aim to address various issues within the healthcare system, such as patient safety, healthcare quality, and cost containment. In the United States, the Centers for Medicare and Medicaid Services (CMS) introduced the Electronic Health Record (EHR) Incentive Program, commonly referred to as "Meaningful Use." This program provides financial incentives to healthcare providers who adopt and demonstrate the meaningful use of EHRs, including e-prescribing.

Various governments around the world have launched healthcare information technology (IT) initiatives to encourage the implementation of EHRs and e-prescribing systems, often providing financial incentives to healthcare organizations that comply. Regulatory bodies like The Joint Commission in the United States and similar organizations globally have recognized e-prescribing as a means to enhance patient safety, thereby encouraging its adoption by healthcare facilities. Governments have played a role in setting standards and promoting interoperability between healthcare systems, ensuring seamless data exchange between different stakeholders in the healthcare ecosystem.

Increased Efficiency and Convenience

One of the primary drivers of the global e-prescribing market is the significant improvement in efficiency it offers. Healthcare providers, including physicians, nurse practitioners, and other prescribers, can easily access patients' medical histories, insurance information, and preferred pharmacies. This information allows them to make informed decisions quickly and prescribe the most suitable medication, eliminating errors and ensuring patient safety. E-prescribing enables real-time communication with pharmacies, reducing waiting times for patients and enhancing overall healthcare delivery. E-prescribing plays a vital role in enhancing patient safety by reducing medication errors. The digitization of prescriptions minimizes the chances of misinterpretation or illegible handwriting, which can lead to adverse drug events. With e-prescribing, drug-drug interaction alerts and dosage recommendations are readily available, assisting prescribers in making informed decisions. This leads to a safer and more effective medication management process for patients.

The adoption of e-prescribing systems has streamlined healthcare workflows for both providers and pharmacies. Prescribers can quickly and accurately send prescriptions to pharmacies, eliminating the need for patients to carry physical prescriptions. Pharmacists, in turn, can efficiently process electronic prescriptions, reducing wait times and enhancing customer satisfaction. These streamlined processes have a significant impact on patient care and overall healthcare system efficiency.

Key Market Challenges

Implementation Barriers

One of the primary challenges faced by the e-prescribing market is the resistance to implementation. Transitioning from paper-based prescription systems to electronic prescribing requires significant investment in both technology and training. Healthcare providers, especially in smaller practices and rural areas, may find it challenging to adapt to new systems, which can lead to slower adoption rates. Moreover, interoperability issues between various electronic health record (EHR) systems and pharmacy software can hinder seamless information exchange. Ensuring that these systems can communicate effectively is crucial for the success of e-prescribing.

Data Privacy and Security

The healthcare industry, including e-prescribing, deals with sensitive patient information. The need to protect patient data from security breaches and unauthorized access is paramount. Healthcare providers and technology companies must invest in robust cybersecurity measures to safeguard electronic health records and prescription data. Compliance with stringent data protection regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, adds complexity to the e-prescribing landscape.

Medication Errors and Decision Support

While e-prescribing can reduce some medication errors associated with illegible handwriting, it introduces new challenges. Decision support tools embedded in e-prescribing systems may generate alerts and suggestions for healthcare providers, but these alerts can sometimes be overwhelming and lead to alert fatigue. Striking the right balance between providing useful guidance and avoiding excessive interruptions in the workflow of healthcare professionals is a significant challenge.

Key Market Trends

Technological Advancements

The global healthcare industry is undergoing a profound transformation, largely driven by the increasing adoption of advanced technologies. One of the significant technological advancements revolutionizing healthcare is e-prescribing, a practice that allows healthcare providers to electronically generate and send prescriptions to pharmacies. E-prescribing has come a long way since its inception in the early 2000s. What started as a convenient alternative to handwritten prescriptions has evolved into a sophisticated system that leverages the power of technology to improve the entire medication management process. In the early days, e-prescribing systems were relatively basic, primarily focused on eliminating errors caused by illegible handwriting. However, today's e-prescribing solutions are significantly more advanced and provide a multitude of benefits for both healthcare providers and patients.

One of the key technological advancements driving the growth of the e-prescribing market is improved interoperability. Modern e-prescribing systems can seamlessly integrate with electronic health records (EHR) and other healthcare information systems. This integration allows healthcare providers to access a patient's complete medical history, drug allergies, and medication records, ensuring that prescriptions are safer and more accurate. Sophisticated decision support tools integrated into e-prescribing systems assist healthcare providers in making more informed decisions. These tools provide real-time drug interaction alerts, dosage recommendations, and generic drug alternatives, thereby enhancing patient safety and helping to reduce medication errors.

The advent of mobile and cloud-based e-prescribing solutions has made it easier for healthcare providers to create and transmit electronic prescriptions from virtually anywhere. This flexibility not only improves efficiency but also allows for more convenient and timely patient care. The rise of telemedicine has further fueled the adoption of e-prescribing. Telehealth consultations often culminate in the need for a prescription, which can be efficiently generated and transmitted electronically through the same platform, enhancing the patient experience. E-prescribing systems have significantly improved in terms of security features. Encryptions, user authentication, and audit trails ensure that patient data remains secure and compliant with privacy regulations. This reassures both healthcare providers and patients.

Segmental Insights

Product Insights

Based on product, solutions emerged as the fastest growing segment in the global market for e-prescribing in 2023. E-prescribing significantly reduces the chances of prescription errors. The ability to access a patient's complete medical history and drug allergies in real-time allows healthcare providers to make informed decisions, leading to safer patient care. It minimizes the risk of misinterpretation of handwritten prescriptions. E-prescribing systems offer automated reminders and alerts for patients, ensuring that they adhere to their prescribed medication regimens. This feature contributes to better health outcomes and reduces the likelihood of hospital readmissions.

Specialties Insights

Based on specialties, the sports medicine segment is projected to experience rapid growth during the forecast period. Sports medicine is a specialized branch of healthcare that focuses on the prevention, diagnosis, treatment, and rehabilitation of injuries and conditions related to physical activity and sports. It encompasses a wide range of medical disciplines, including orthopedics, physical therapy, sports science, nutrition, and more. As the popularity of sports and physical fitness continues to rise, the demand for sports medicine services has grown significantly.

Athletes frequently encounter injuries that require specialized treatments and medications. E-prescribing simplifies the process of prescribing medications and rehabilitation equipment, allowing sports medicine professionals to quickly and accurately provide the necessary care. This not only accelerates the recovery process but also reduces the risk of medication errors. In the high-pressure world of sports, it is crucial to ensure that athletes receive the right medication at the right time. E-prescribing systems come with safety features, such as drug interaction checks and allergy alerts, that help sports medicine practitioners avoid potentially dangerous medication combinations. E-prescribing promotes better communication between sports medicine practitioners, athletes, and pharmacists. When a prescription is electronically transmitted, the pharmacist can easily access detailed information, enabling them to prepare the medication and equipment more efficiently. This seamless collaboration ensures that athletes receive the most effective treatment.

Regional Insights

Based on region, North America emerged as the dominant region in the Global E-Prescribing Market in 2023, holding the largest market share in terms of value. One of the primary reasons for North America's prominence in the e-prescribing market is the robust regulatory support and framework in place. The United States, in particular, has played a pivotal role in shaping e-prescribing guidelines and standards. The Drug Enforcement Administration (DEA) established the Electronic Prescriptions for Controlled Substances (EPCS) rule, allowing the electronic prescribing of controlled substances, which was a significant milestone in advancing e-prescribing technology. E-prescribing systems significantly enhance patient safety by reducing medication errors, which are a significant concern in healthcare. These systems allow healthcare providers to access patients' medication histories, check for potential drug interactions, and provide accurate dosage information, leading to a decrease in adverse drug events. Patients can also receive their prescriptions directly at the pharmacy, eliminating the need for paper prescriptions that can be lost or misinterpreted. This emphasis on patient safety has been a driving factor behind the adoption of e-prescribing in North America.

Key Market Players

Oracle Corp.

Veradigm LLC

Epic Systems Corporation

Athenahealth, Inc.

NextGen Healthcare, Inc.

McKesson Corporation

Surescripts, LLC

Change Healthcare LLC

Practice Fusion, Inc.

Networking Technology, Inc.

Report Scope:

In this report, the Global E-Prescribing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

E-Prescribing Market, By Product:

Solutions Services

E-Prescribing Market, By Specialties:

Oncology Sports Medicine Neurology Cardiology Others

E-Prescribing Market, By Delivery Mode:

Web/Cloud Based On Premise

E-Prescribing Market, By Substances:

Controlled Substances Non-controlled Substances

E-Prescribing Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global E-Prescribing Market.

Available Customizations:

Global E-Prescribing Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global E-Prescribing Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product (Solutions (Integrated Solutions, Standalone Solutions), Services(Support, Implementation, Training, Network)
  • 4.2.2. By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others)
  • 4.2.3. By Delivery Mode (Web/Cloud Based, On Premise)
  • 4.2.4. By Substances (Controlled Substances, Non-controlled Substances)
  • 4.2.5. By Region
  • 4.2.6. By Company (2023)
• 4.3. Market Map
  • 4.3.1. By Product
  • 4.3.2. By Specialties
  • 4.3.3. By Delivery Mode
  • 4.3.4. By Substances
  • 4.3.5. By Region

5. Asia Pacific E-Prescribing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product
  • 5.2.2. By Specialties
  • 5.2.3. By Delivery Mode
  • 5.2.4. By Substances
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China E-Prescribing Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product
      • 5.3.1.2.2. By Specialties
      • 5.3.1.2.3. By Delivery Mode
      • 5.3.1.2.4. By Substances
  • 5.3.2. India E-Prescribing Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product
      • 5.3.2.2.2. By Specialties
      • 5.3.2.2.3. By Delivery Mode
      • 5.3.2.2.4. By Substances
  • 5.3.3. Australia E-Prescribing Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product
      • 5.3.3.2.2. By Specialties
      • 5.3.3.2.3. By Delivery Mode
      • 5.3.3.2.4. By Substances
  • 5.3.4. Japan E-Prescribing Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product
      • 5.3.4.2.2. By Specialties
      • 5.3.4.2.3. By Delivery Mode
      • 5.3.4.2.4. By Substances
  • 5.3.5. South Korea E-Prescribing Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product
      • 5.3.5.2.2. By Specialties
      • 5.3.5.2.3. By Delivery Mode
      • 5.3.5.2.4. By Substances

6. Europe E-Prescribing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Specialties
  • 6.2.3. By Delivery Mode
  • 6.2.4. By Substances
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France E-Prescribing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Specialties
      • 6.3.1.2.3. By Delivery Mode
      • 6.3.1.2.4. By Substances
  • 6.3.2. Germany E-Prescribing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Specialties
      • 6.3.2.2.3. By Delivery Mode
      • 6.3.2.2.4. By Substances
  • 6.3.3. Spain E-Prescribing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Specialties
      • 6.3.3.2.3. By Delivery Mode
      • 6.3.3.2.4. By Substances
  • 6.3.4. Italy E-Prescribing Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product
      • 6.3.4.2.2. By Specialties
      • 6.3.4.2.3. By Delivery Mode
      • 6.3.4.2.4. By Substances
  • 6.3.5. United Kingdom E-Prescribing Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product
      • 6.3.5.2.2. By Specialties
      • 6.3.5.2.3. By Delivery Mode
      • 6.3.5.2.4. By Substances

7. North America E-Prescribing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Specialties
  • 7.2.3. By Delivery Mode
  • 7.2.4. By Substances
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States E-Prescribing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Specialties
      • 7.3.1.2.3. By Delivery Mode
      • 7.3.1.2.4. By Substances
  • 7.3.2. Mexico E-Prescribing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Specialties
      • 7.3.2.2.3. By Delivery Mode
      • 7.3.2.2.4. By Substances
  • 7.3.3. Canada E-Prescribing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Specialties
      • 7.3.3.2.3. By Delivery Mode
      • 7.3.3.2.4. By Substances

8. South America E-Prescribing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Specialties
  • 8.2.3. By Delivery Mode
  • 8.2.4. By Substances
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil E-Prescribing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Specialties
      • 8.3.1.2.3. By Delivery Mode
      • 8.3.1.2.4. By Substances
  • 8.3.2. Argentina E-Prescribing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Specialties
      • 8.3.2.2.3. By Delivery Mode
      • 8.3.2.2.4. By Substances
  • 8.3.3. Colombia E-Prescribing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Specialties
      • 8.3.3.2.3. By Delivery Mode
      • 8.3.3.2.4. By Substances

9. Middle East and Africa E-Prescribing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Specialties
  • 9.2.3. By Delivery Mode
  • 9.2.4. By Substances
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa E-Prescribing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Specialties
      • 9.3.1.2.3. By Delivery Mode
      • 9.3.1.2.4. By Substances
  • 9.3.2. Saudi Arabia E-Prescribing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Specialties
      • 9.3.2.2.3. By Delivery Mode
      • 9.3.2.2.4. By Substances
  • 9.3.3. UAE E-Prescribing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Specialties
      • 9.3.3.2.3. By Delivery Mode
      • 9.3.3.2.4. By Substances

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global E-Prescribing Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Oracle Corp.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Veradigm LLC
• 14.3. Epic Systems Corporation
• 14.4. Athenahealth, Inc.
• 14.5. NextGen Healthcare, Inc.
• 14.6. McKesson Corporation
• 14.7. Surescripts, LLC
• 14.8. Change Healthcare LLC
• 14.9. Practice Fusion, Inc.
• 14.10.Networking Technology, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer